» Authors » Stefanie Reinhardt

Stefanie Reinhardt

Explore the profile of Stefanie Reinhardt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 445
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fischbach F, Richter J, Pfeffer L, Fehse B, Berger S, Reinhardt S, et al.
Med . 2024 Mar; 5(6):550-558.e2. PMID: 38554710
Background: Progressive multiple sclerosis (MS) is characterized by compartmentalized smoldering neuroinflammation caused by the proliferation of immune cells residing in the central nervous system (CNS), including B cells. Although inflammatory...
2.
Braun B, Fischbach F, Richter J, Pfeffer L, Fay H, Reinhardt S, et al.
Mult Scler Relat Disord . 2024 Jan; 82:105414. PMID: 38176284
Background: Autologous hematopoietic stem cell transplantation (aHSCT) exhibits promising results for multiple sclerosis (MS) in the short term. We investigated the long-term outcome differences in disease progression and cognitive impairment...
3.
Rosenkranz S, Gutmann L, Has Silemek A, Dorr M, Haussler V, Lupke M, et al.
J Neurol Neurosurg Psychiatry . 2023 Jul; 94(11):924-933. PMID: 37433662
Background: Neurodegeneration in multiple sclerosis (MS) affects the visual system but dynamics and pathomechanisms over several years especially in primary progressive MS (PPMS) are not fully understood. Methods: We assessed...
4.
Eghbalzadeh K, Guschlbauer M, Weber C, Wacker M, Reinhardt S, Djordjevic I, et al.
Thorac Cardiovasc Surg . 2019 Apr; 69(7):649-659. PMID: 31030422
Background:  Scientific attempts to create the "ideal" small diameter vascular graft have been compared with the "search of the holy grail." Prosthetic material as expanded polytetrafluoroethylene or Dacron shows acceptable...
5.
Stoessel D, Stellmann J, Willing A, Behrens B, Rosenkranz S, Hodecker S, et al.
Front Hum Neurosci . 2018 Jun; 12:226. PMID: 29915533
Primary progressive multiple sclerosis (PPMS) shows a highly variable disease progression with poor prognosis and a characteristic accumulation of disabilities in patients. These hallmarks of PPMS make it difficult to...
6.
Willing A, Jager J, Reinhardt S, Kursawe N, Friese M
J Immunol . 2018 Jan; 200(3):974-982. PMID: 29298833
Multiple sclerosis (MS) is a T cell-driven inflammatory disease of the CNS. Research on T cell subsets involved in MS pathogenesis has mainly focused on classical CD4 T cells, especially...
7.
Sturner K, Stellmann J, Dorr J, Paul F, Friede T, Schammler S, et al.
J Neurol Neurosurg Psychiatry . 2017 Dec; 89(4):330-338. PMID: 29248894
Objective: To investigate whether oral administration of a standardised frankincense extract (SFE) is safe and reduces disease activity in patients with relapsing-remitting multiple sclerosis (RRMS). Methods: We performed an investigator-initiated,...
8.
Weber C, Reinhardt S, Eghbalzadeh K, Wacker M, Guschlbauer M, Maul A, et al.
J Vasc Surg . 2017 Dec; 68(6S):177S-187S.e1. PMID: 29248244
Objective: Despite the clinical success of large-diameter vascular grafts, synthetic grafts in small-diameter vessels are of limited use because of their poor patency rates. Previous experiments of our group provided...
9.
Piedavent-Salomon M, Willing A, Engler J, Steinbach K, Bauer S, Eggert B, et al.
Brain . 2015 Sep; 138(Pt 11):3263-74. PMID: 26359290
Recent association studies have linked numerous genetic variants with an increased risk for multiple sclerosis, although their functional relevance remains largely unknown. Here we investigated phenotypical and functional consequences of...
10.
Lutterotti A, Yousef S, Sputtek A, Sturner K, Stellmann J, Breiden P, et al.
Sci Transl Med . 2013 Jun; 5(188):188ra75. PMID: 23740901
Multiple sclerosis (MS) is a devastating inflammatory disease of the brain and spinal cord that is thought to result from an autoimmune attack directed against antigens in the central nervous...